HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Irish Tax Office Pauses Supplement Tax Thanks To Pressure From Industry

Executive Summary

Ireland halts imposition of a 23% value-added tax (VAT) on food supplements thanks in part to public campaigning by the Irish Health Trade Association (IHTA).

You may also be interested in...



Switchers, apply here, says HPRA

Irish medicines agency, the HPRA, has said it is “open” to prescription-to-OTC switch applications, especially if they are first-in-category switches, and will offer advice to firms that apply.

Rowex launches OTC sumatriptan in Ireland

Migraine sufferers in Ireland will for the first time be able to access a sumatriptan product without a prescription thanks to the OTC launch of Rowex’s Sumatran Relief.

CBD In Cosmetics: The State Of the European Union

HBW Insight speaks to EU regulatory expert Amanda Isom of Bloom Regulatory Ltd about the current state of play in Europe’s CBD cosmetics market, reflecting on how it compares with the situation in US, and the EU market for CBD food supplements.

Topics

UsernamePublicRestriction

Register

LL1133273

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel